Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2OTHER_GOV 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 4CNS 4Other hematologic neoplasm 3Head & Neck 3Sarcoma 2Plasma cell 1Myeloid 1Gastrointestinal 1Dermatologic 1Classical hematology 1

Conditions

Sarcoma, Kaposi 2Sarcoma 1

Interventions

Radiotherapy 137Cyclophosphamide 132Temozolomide 116Doxorubicin 99Filgrastim 68Ifosfamide 64Gemcitabine 58Etoposide 55Bevacizumab 51Imatinib Mesylate 50fludarabine phosphate 49Irinotecan 46pembrolizumab 45Peripheral Blood Stem Cell Transplantation 45pazopanib 43Magnetic Resonance Spectroscopy 42Methotrexate 40Carboplatin 40Busulfan 40Vincristine 38Surgical Procedures, Operative 37Nivolumab 37Melphalan 37Cisplatin 36Radiation 34Blood Specimen Collection 33Mycophenolic Acid 31Cyclosporine 31Docetaxel 29Trabectedin 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Valganciclovir × Sarcoma × Clear all
NCT00096538 2015-11-25

Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma

Memorial Sloan Kettering Cancer Center

Phase NA Completed
6 enrolled 6 charts
Sarcoma

Sarcoma, Sarcoma, Kaposi

NCT00194467 2008-01-10

Suppression of Oral HHV8 Shedding With Valganciclovir

University of Washington

Phase 2 Completed
32 enrolled
Sarcoma

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡